News
Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States
CHICAGO, IL, USA I April 03, 2025 I Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago focused on the ...
Embecta (Nasdaq:EMBC) announced a new publication introducing best practices for insulin injection techniques and education.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback